Media Summary: David Porter, University of Pennsylvania. Harpreet Singh, Immatics Biotechnologies. Lisa Butterfield, University of Pittsburgh.

2 29 2016 Session 3 - Detailed Analysis & Overview

David Porter, University of Pennsylvania. Harpreet Singh, Immatics Biotechnologies. Lisa Butterfield, University of Pittsburgh. Rajeshwari Sridhara, FDA Center for Drug Evaluation and Research. Peter Bross, FDA Center for Biologics Evaluation and Research. Panelists field questions from the audience.

Steven Rosenberg, National Cancer Institute. Whitney Helms, FDA Center for Drug Evaluation and Research. Alexandra Snyder Charen, Memorial Sloan Kettering Cancer Center. Bernard Fox, Earle A. Chiles Research Institute. Malcolm Brenner, Baylor College of Medicine. Testimony of Chhun Samorn Left Channel audio: Floor Right channel audio: Khmer Please adjust the balance in your system's ...

Photo Gallery

2/29/2016 - Session 3: Porter
2/29/2016 - Session 3: Singh
2/29/2016 - Session 3: Butterfield
2/29/2016 - Session 3: Simon
2/29/2016 - Session 3: Sridhara
2/29/2016 - Session 3: Bross
2/29/2016 - Session 3: Panel Q&A
2/29/2016 - Session 1:  Rosenberg
2/29/2016 - Session 2:  Helms
2/29/2016 - Session 2: Snyder
2/29/2016 - Session 2: Fox
2/29/2016 - Session 1: Brenner
View Detailed Profile
2/29/2016 - Session 3: Porter

2/29/2016 - Session 3: Porter

David Porter, University of Pennsylvania.

2/29/2016 - Session 3: Singh

2/29/2016 - Session 3: Singh

Harpreet Singh, Immatics Biotechnologies.

2/29/2016 - Session 3: Butterfield

2/29/2016 - Session 3: Butterfield

Lisa Butterfield, University of Pittsburgh.

2/29/2016 - Session 3: Simon

2/29/2016 - Session 3: Simon

Rich Simon, National Cancer Institute.

2/29/2016 - Session 3: Sridhara

2/29/2016 - Session 3: Sridhara

Rajeshwari Sridhara, FDA Center for Drug Evaluation and Research.

2/29/2016 - Session 3: Bross

2/29/2016 - Session 3: Bross

Peter Bross, FDA Center for Biologics Evaluation and Research.

2/29/2016 - Session 3: Panel Q&A

2/29/2016 - Session 3: Panel Q&A

Panelists field questions from the audience.

2/29/2016 - Session 1:  Rosenberg

2/29/2016 - Session 1: Rosenberg

Steven Rosenberg, National Cancer Institute.

2/29/2016 - Session 2:  Helms

2/29/2016 - Session 2: Helms

Whitney Helms, FDA Center for Drug Evaluation and Research.

2/29/2016 - Session 2: Snyder

2/29/2016 - Session 2: Snyder

Alexandra Snyder Charen, Memorial Sloan Kettering Cancer Center.

2/29/2016 - Session 2: Fox

2/29/2016 - Session 2: Fox

Bernard Fox, Earle A. Chiles Research Institute.

2/29/2016 - Session 1: Brenner

2/29/2016 - Session 1: Brenner

Malcolm Brenner, Baylor College of Medicine.

Session 3 - 28 June 2016 - Case 002/02 - FL/KH

Session 3 - 28 June 2016 - Case 002/02 - FL/KH

Testimony of Chhun Samorn Left Channel audio: Floor Right channel audio: Khmer Please adjust the balance in your system's ...